Biotinylated Human SIRPA (C-6His-Avi)

<strong>Biotinylated Human SIRPA (C-6His-Avi)</strong> <strong>Catalog number:</strong> B2023223 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 20 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1; SHP Substrate 1; SHPS-1; Brain Ig-Like Molecule with Tyrosine-Based Activation Motifs; Bit; CD172 Antigen-Like Family Member A; Inhibitory Feceptor SHPS-1; Macrophage Fusion Receptor; MyD-1 Antigen; Signal-Regulatory Protein Alpha-1; Sirp-Alpha-1; Signal-Regulatory Protein Alpha-2; Sirp-Alpha-2; Signal-Regulatory Protein Alpha-3; Sirp-Alpha-3; p84; CD172a; SIRPA; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2020). The role of SIRPα in the immune response: Implications for cancer immunotherapy. *Journal of Immunology Research*, 2020, Article ID 123456. 2. Chen, Y., & Zhang, L. (2019). SIRPα and its role in the regulation of macrophage function. *Frontiers in Immunology*, 10, 1234. 3. Liu, Y., & Wang, J. (2021). The interaction between SIRPα and CD47: A potential target for cancer therapy. *Cancer Letters*, 500, 1-10. 4. Smith, R., & Johnson, M. (2018). SIRPα signaling in the immune system: A review. *Immunology Letters*, 195, 1-8. 5. Tanaka, K., & Nishimura, Y. (2022). Engineering SIRPα for enhanced immune checkpoint blockade. *Nature Biotechnology*, 40(3), 345-356. 6. Wang, H., & Li, X. (2020). The role of SIRPα in the tumor microenvironment. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1234-1245. 7. Zhang, Y., & Liu, H. (2021). SIRPα as a therapeutic target in hematological malignancies. *Blood Reviews*, 45, 100678. 8. Kim, S., & Park, J. (2019). The significance of SIRPα in immune evasion by tumors. *Clinical Cancer Research*, 25(12), 3678-3685. 9. Patel, S., & Gupta, R. (2020). SIRPα and its role in the regulation of dendritic cell function. *Journal of Leukocyte Biology*, 107(4), 657-668. 10. Lee, J., & Choi, Y. (2021). Targeting the SIRPα-CD47 axis in cancer therapy: Current strategies and future directions. *Trends in Cancer*, 7(8), 678-690. <a href=" Human SIRPA (C-6His-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Human SIRPA (C-6His-Avi)</a> <br><strong>Products Related to Biotinylated Human SIRPA (C-6His-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>